Diarrhea is one of the most common causes of death in young piglets. Porcine rotavirus (PoRV) belongs to the genus Rotavirus within the family Reoviridae, and is considered to be the primary pathogen causing diarrhea in piglets. Portulaca oleracea L. (POL) has been reported to alleviate diarrhea and viral infections. However, the antiviral effect of Portulaca oleracea L. polysaccharide (POL-P), an active component of POL, on PoRV infection remains unclear. This study demonstrated that the safe concentration range of POL-P in IPEC-J2 cells is 0–400 μg/mL. POL-P (400 μg/mL) effectively inhibits PoRV infection in IPEC-J2 cells, reducing the expression of rotavirus VP6 protein, mRNA and virus titer. Furthermore, on the basis of viral life cycle analysis, we showed that POL-P can decrease the expression of PoRV VP6 protein, mRNA, and virus titer during the internalization and replication stages of PoRV. POL-P exerts antiviral effects by increasing IFN-α expression and decreasing the expression levels of TNF-α, IL-6, and IL-10 inflammatory factors. Overall, our study found that POL-P is a promising candidate for anti-PoRV drugs.
Aims: This study combines traditional Chinese medicine polysaccharides with nanomaterials to enhance drug bioavailability and immunological activity. Background: The study of polysaccharide preparation, structure identification, pharmacological activity, and mechanism of action is deepening, but the research combined with the new drug delivery system is relatively weak, so the application of polysaccharides is still facing great limitations. In order to prolong the action time of polysaccharides and improve their bioavailability, liposome has become the most promising delivery carrier. Objectives: The purpose of this study was to optimize the preparation process of Portulaca oleracea L. polysaccharides liposomes (POL-PL) and evaluate the immunoactivity in vitro. Methods: POL-PL was prepared by reverse evaporation, and the preparation process was optimized using the response surface methodology. The characteristic analysis of POL-PL was detected by the indicators including morphology, particle size, zeta potential, encapsulation efficiency, release, and stability. The effects of POL-PL on the proliferation and immunological activity of mouse spleen lymphocytes and RAW264.7 cells were evaluated in vitro. Results: POL-PL is highly homogeneous in morphology and particle size, and its sustained release improves the bioavailability of Portulaca oleracea L. polysaccharides (POL-P). Moreover, POL-PL treatment significantly enhanced the proliferation and phagocytic activity of RAW264.7 cells and increased the secretion of IL-6, TNF-α, IL-1β, and NO. Conclusion: This study suggested that POL-PL were prepared successfully by reverse evaporation method, and POL-PL had immunoenhancing activity in vitro. The results provided a theoretical basis for further application of POL-PL.
17 June 2026 in Applied and Environmental Microbiology
Porcine epidemic diarrhea (PED) is a highly lethal and airborne disease in neonatal piglets that has caused significant economic losses in the pig industry over the last three decades. Despite the widespread implementation of commercial vaccines, the disease continues to exhibit recurrent outbreaks, primarily owing to suboptimal immunization efficacy. In this study, we engineered recombinant Lactiplantibacillus plantarum LP12:PEDV tS1, which expresses the truncated S1 domain of the porcine epidemic diarrhea virus (PEDV) spike protein through a surface anchoring mechanism. The expression was confirmed using western blotting, flow cytometry, and indirect immunofluorescence assays, with a maximum protein yield of 1.7657 μg per 1×10 9 CFU. Furthermore, we immunized mice and pigs nasally with LP12:PEDV tS1 separately. Immunization elicited robust mucosal immune responses, as evidenced by a significant increase in specific secretory IgA (sIgA) with neutralizing activity in alveolar lavage fluid and fecal samples. Our results also indicated that LP12:PEDV tS1 activated dendritic cells in the mesenteric lymph nodes of mice, marked by notable upregulation of CD80 and CD86. Successive immunization with LP12:PEDV tS1 protected piglets from PEDV infection and elicited comparable mucosal immune responses across species, demonstrating its strong potential as a PEDV vaccine candidate. Moreover, an intranasal immunization strategy based on recombinant Lactiplantibacillus plantarum demonstrated suitability for cross-species vaccination between mice and piglets, potentially streamlining the preclinical evaluation process. IMPORTANCE: Porcine epidemic diarrhea (PED) is a major cause of piglet mortality. Current control relies on vaccinating pregnant sows with inactivated or attenuated viruses. However, not all sows develop sufficient antibodies to protect piglets. Once piglets are infected, no effective emergency vaccines are available for them, as existing options pose biosafety risks. To address this, we developed a subunit mucosal vaccine using recombinant Lactiplantibacillus plantarum . This vaccine is cost-effective, enables cross-species immunization, and remarkably provides immediate immunity to prevent viral infection in neonatal piglets.